Honickel, M., Braunschweig, T., Ryn, J. V., Rossaint, R., & Grottke, O. (2015). Efficacy of idarucizumab, prothrombin complex concentrate (PCC) and activated PCC to reverse the anticoagulatory potential of dabigatran in a porcine polytrauma model. Crit Care.
Citação norma ChicagoHonickel, M., T. Braunschweig, J Van Ryn, R. Rossaint, and O. Grottke. "Efficacy of Idarucizumab, Prothrombin Complex Concentrate (PCC) and Activated PCC to Reverse the Anticoagulatory Potential of Dabigatran in a Porcine Polytrauma Model." Crit Care 2015.
Citação norma MLAHonickel, M., et al. "Efficacy of Idarucizumab, Prothrombin Complex Concentrate (PCC) and Activated PCC to Reverse the Anticoagulatory Potential of Dabigatran in a Porcine Polytrauma Model." Crit Care 2015.